CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $135,956 | -19.6% | 105,392 | +7.3% | 0.00% | – |
Q2 2023 | $169,016 | +90.5% | 98,265 | +67.2% | 0.00% | – |
Q1 2023 | $88,735 | -5.6% | 58,765 | 0.0% | 0.00% | – |
Q4 2022 | $94,024 | +16.1% | 58,765 | +5.4% | 0.00% | – |
Q3 2022 | $81,000 | +26.6% | 55,765 | +60.5% | 0.00% | – |
Q2 2022 | $64,000 | -34.0% | 34,740 | +82.1% | 0.00% | – |
Q3 2021 | $97,000 | -47.8% | 19,075 | -35.1% | 0.00% | – |
Q2 2021 | $186,000 | +5.1% | 29,400 | +28.4% | 0.00% | – |
Q1 2021 | $177,000 | – | 22,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |